Literature DB >> 26259563

Color vision impairment in multiple sclerosis points to retinal ganglion cell damage.

E J Lampert1, M Andorra1, R Torres-Torres2, S Ortiz-Pérez2, S Llufriu1, M Sepúlveda1, N Sola1, A Saiz1, B Sánchez-Dalmau2, P Villoslada1, Elena H Martínez-Lapiscina3.   

Abstract

Multiple Sclerosis (MS) results in color vision impairment regardless of optic neuritis (ON). The exact location of injury remains undefined. The objective of this study is to identify the region leading to dyschromatopsia in MS patients' NON-eyes. We evaluated Spearman correlations between color vision and measures of different regions in the afferent visual pathway in 106 MS patients. Regions with significant correlations were included in logistic regression models to assess their independent role in dyschromatopsia. We evaluated color vision with Hardy-Rand-Rittler plates and retinal damage using Optical Coherence Tomography. We ran SIENAX to measure Normalized Brain Parenchymal Volume (NBPV), FIRST for thalamus volume and Freesurfer for visual cortex areas. We found moderate, significant correlations between color vision and macular retinal nerve fiber layer (rho = 0.289, p = 0.003), ganglion cell complex (GCC = GCIP) (rho = 0.353, p < 0.001), thalamus (rho = 0.361, p < 0.001), and lesion volume within the optic radiations (rho = -0.230, p = 0.030). Only GCC thickness remained significant (p = 0.023) in the logistic regression model. In the final model including lesion load and NBPV as markers of diffuse neuroaxonal damage, GCC remained associated with dyschromatopsia [OR = 0.88 95 % CI (0.80-0.97) p = 0.016]. This association remained significant when we also added sex, age, and disease duration as covariates in the regression model. Dyschromatopsia in NON-eyes is due to damage of retinal ganglion cells (RGC) in MS. Color vision can serve as a marker of RGC damage in MS.

Entities:  

Keywords:  Color vision; Magnetic resonance imaging; Optical coherence tomography; Retinal ganglion cell; Visual pathway

Mesh:

Year:  2015        PMID: 26259563     DOI: 10.1007/s00415-015-7876-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  A direct demonstration of functional specialization in human visual cortex.

Authors:  S Zeki; J D Watson; C J Lueck; K J Friston; C Kennard; R S Frackowiak
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

2.  Ganglion cell loss in relation to visual disability in multiple sclerosis.

Authors:  Scott D Walter; Hiroshi Ishikawa; Kristin M Galetta; Reiko E Sakai; Daniel J Feller; Sam B Henderson; James A Wilson; Maureen G Maguire; Steven L Galetta; Elliot Frohman; Peter A Calabresi; Joel S Schuman; Laura J Balcer
Journal:  Ophthalmology       Date:  2012-02-23       Impact factor: 12.079

3.  Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Authors:  Iñigo Gabilondo; Elena H Martínez-Lapiscina; Eloy Martínez-Heras; Elena Fraga-Pumar; Sara Llufriu; Santiago Ortiz; Santiago Bullich; Maria Sepulveda; Carles Falcon; Joan Berenguer; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

4.  An fMRI version of the Farnsworth-Munsell 100-Hue test reveals multiple color-selective areas in human ventral occipitotemporal cortex.

Authors:  M S Beauchamp; J V Haxby; J E Jennings; E A DeYoe
Journal:  Cereb Cortex       Date:  1999 Apr-May       Impact factor: 5.357

5.  Colour vision impairment is associated with disease severity in multiple sclerosis.

Authors:  Elena H Martínez-Lapiscina; Santiago Ortiz-Pérez; Elena Fraga-Pumar; Eloy Martínez-Heras; Iñigo Gabilondo; Sara Llufriu; Santiago Bullich; Marc Figueras; Albert Saiz; Bernardo Sánchez-Dalmau; Pablo Villoslada
Journal:  Mult Scler       Date:  2014-01-07       Impact factor: 6.312

6.  Color vision is strongly associated with retinal thinning in multiple sclerosis.

Authors:  Pablo Villoslada; Ami Cuneo; Jeffrey Gelfand; Stephen L Hauser; Ari Green
Journal:  Mult Scler       Date:  2012-01-30       Impact factor: 6.312

7.  Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.

Authors:  Stella Maris Costa Castro; Alfredo Damasceno; Benito Pereira Damasceno; Jose Paulo de Vasconcellos; Fabiano Reis; Josie Naomi Iyeyasu; Keila Monteiro de Carvalho
Journal:  Arq Neuropsiquiatr       Date:  2013-07       Impact factor: 1.420

8.  The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test.

Authors:  Barry L Cole; Ka-Yee Lian; Carol Lakkis
Journal:  Clin Exp Optom       Date:  2006-03       Impact factor: 2.742

9.  Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.

Authors:  Jorge Sepulcre; Joaquín Goñi; Joseph C Masdeu; Bartolome Bejarano; Nieves Vélez de Mendizábal; Juan B Toledo; Pablo Villoslada
Journal:  Arch Neurol       Date:  2009-02

10.  Cortical folding patterns and predicting cytoarchitecture.

Authors:  Bruce Fischl; Niranjini Rajendran; Evelina Busa; Jean Augustinack; Oliver Hinds; B T Thomas Yeo; Hartmut Mohlberg; Katrin Amunts; Karl Zilles
Journal:  Cereb Cortex       Date:  2007-12-12       Impact factor: 5.357

View more
  19 in total

1.  Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.

Authors:  Athina Papadopoulou; Laura Gaetano; Armanda Pfister; Anna Altermatt; Charidimos Tsagkas; Felix Morency; Alexander U Brandt; Martin Hardmeier; Mallar M Chakravarty; Maxime Descoteaux; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  Neurology       Date:  2019-04-10       Impact factor: 9.910

Review 2.  Optical coherence tomography in multiple sclerosis.

Authors:  Josefine Britze; Jette Lautrup Frederiksen
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

3.  Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease.

Authors:  V Polo; M J Rodrigo; E Garcia-Martin; S Otin; J M Larrosa; M I Fuertes; M P Bambo; L E Pablo; M Satue
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

Review 4.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

5.  Visual field impairment captures disease burden in multiple sclerosis.

Authors:  Santiago Ortiz-Perez; Magí Andorra; Bernardo Sanchez-Dalmau; Rubén Torres-Torres; David Calbet; Erika J Lampert; Salut Alba-Arbalat; Ana M Guerrero-Zamora; Irati Zubizarreta; Nuria Sola-Valls; Sara Llufriu; María Sepúlveda; Albert Saiz; Pablo Villoslada; Elena H Martinez-Lapiscina
Journal:  J Neurol       Date:  2016-02-09       Impact factor: 4.849

Review 6.  Monitoring the Course of MS With Optical Coherence Tomography.

Authors:  Alexander U Brandt; Elena H Martinez-Lapiscina; Rachel Nolan; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

7.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

Review 8.  Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.

Authors:  Josefine Britze; Gorm Pihl-Jensen; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2017-05-31       Impact factor: 4.849

9.  Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging.

Authors:  Caspar B Seitz; Amgad Droby; Lena Zaubitzer; Julia Krämer; Mathieu Paradis; Luisa Klotz; Heinz Wiendl; Sergiu Groppa; Sven G Meuth; Frauke Zipp; Vinzenz Fleischer
Journal:  J Neurol       Date:  2018-08-02       Impact factor: 4.849

10.  Ability of swept source OCT to detect retinal changes in patients with bipolar disorder.

Authors:  Vicente Polo; Maria Satue; Alicia Gavin; Elisa Vilades; Elvira Orduna; Marta Cipres; Javier Garcia-Campayo; Mayte Navarro-Gil; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin
Journal:  Eye (Lond)       Date:  2018-10-31       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.